subject area of
- BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase Journal Articles
- Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor) Journal Articles
- Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors Including Gastrointestinal Stromal Tumors Journal Articles
- Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib Journal Articles
- Esophageal gastrointestinal stromal tumor: report of 7 patients Journal Articles
-
Final report of
TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD ) study Journal Articles -
Gender and
BCR ‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia Journal Articles - Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study Journal Articles
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin Journal Articles
- Imatinib mesylate in children and adolescents with cancer Journal Articles
- Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma Journal Articles
- Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial Journal Articles
- Short- and long-term effects of imatinib in hospitalised COVID-19 patients: A randomised trial Journal Articles
- Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results Journal Articles
- The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia Journal Articles
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease Journal Articles
- XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from Molecular Pathogenesis to Targeted Therapy in Leukemia and Solid Tumors Conferences